{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T18:29:32Z","timestamp":1775932172353,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.diabres.2018.03.014","type":"journal-article","created":{"date-parts":[[2018,3,11]],"date-time":"2018-03-11T01:22:00Z","timestamp":1520731320000},"page":"272-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Statin-induced myopathy SLCO1B1 521T\u202f&gt;\u202fC is associated with prediabetes, high body mass index and normal lipid profile in Emirati population"],"prefix":"10.1016","volume":"139","author":[{"given":"Maha","family":"Saber-Ayad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaista","family":"Manzoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"El-Serafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5394-9082","authenticated-orcid":false,"given":"Ibrahim","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salah","family":"Abusnana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2018.03.014_b0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2133\/dmpk.23.223","article-title":"Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs","volume":"23","author":"Maeda","year":"2008","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.diabres.2018.03.014_b0010","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/S0140-6736(11)61125-2","article-title":"Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial","volume":"378","author":"Bulbulia","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2018.03.014_b0015","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2018.03.014_b0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature14177","article-title":"Genetic studies of body mass index yield new insights for obesity biology","volume":"518","author":"Locke","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.diabres.2018.03.014_b0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature14132","article-title":"New genetic loci link adipose and insulin biology to body fat distribution","volume":"518","author":"Shungin","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.diabres.2018.03.014_b0030","doi-asserted-by":"crossref","first-page":"35669","DOI":"10.1074\/jbc.M103792200","article-title":"Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans","volume":"276","author":"Tirona","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diabres.2018.03.014_b0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/FPC.0b013e32834d4962","article-title":"PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19","volume":"22","author":"Scott","year":"2012","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.diabres.2018.03.014_b0040","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2125.2007.02892.x","article-title":"SLCO1B1 521T\u2192C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients","volume":"64","author":"Zhang","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.diabres.2018.03.014_b0045","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2125.2006.02686.x","article-title":"Effect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinide","volume":"62","author":"Zhang","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.diabres.2018.03.014_b0050","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/sj.tpj.6500328","article-title":"An association study of 43 SNPs in 16 candidate genes with atorvastatin response","volume":"5","author":"Thompson","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.diabres.2018.03.014_b0055","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2217\/14622416.9.9.1217","article-title":"Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy","volume":"9","author":"Couvert","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.diabres.2018.03.014_b0060","article-title":"Genetic variation at the slco1b1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly","author":"Akao","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.diabres.2018.03.014_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/clpt.2014.125","article-title":"The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy 2014 update suppl material","volume":"96","author":"Ramsey","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.diabres.2018.03.014_b0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2217\/14622416.9.1.19","article-title":"Global analysis of genetic variation in SLCO1B1","volume":"9","author":"Pasanen","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.diabres.2018.03.014_b0075","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00228-007-0409-y","article-title":"Comparison of SLCO1B1 sequence variability among German, Turkish, and African populations","volume":"64","author":"Mwinyi","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.diabres.2018.03.014_b0080","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ng.686","article-title":"Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index","volume":"42","author":"Speliotes","year":"2010","journal-title":"Nat Genet"},{"issue":"1045\u20131053","key":"10.1016\/j.diabres.2018.03.014_b0085","first-page":"e6","article-title":"FGF21 is a sugar-induced hormone associated with sweet intake and preference in humans","volume":"25","author":"S\u00f8berg","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.diabres.2018.03.014_b0090","unstructured":"EO. LDL cholesterol was more strongly associated with percent body fat than body mass index and waist circumference in a health screening population. Obes Res Clin Pr 2017; 17."},{"key":"10.1016\/j.diabres.2018.03.014_b0095","unstructured":"FDA. FDA: Limit Use of 80 mg Simvastatin. Consum Heal Inf; 2011:1."},{"key":"10.1016\/j.diabres.2018.03.014_b0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40256-014-0096-x","article-title":"Simvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database","volume":"15","author":"Tuchscher","year":"2015","journal-title":"Am J Cardiovasc Drugs"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822717319290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822717319290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T12:15:07Z","timestamp":1656245707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822717319290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":20,"alternative-id":["S0168822717319290"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2018.03.014","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statin-induced myopathy SLCO1B1 521T\u202f>\u202fC is associated with prediabetes, high body mass index and normal lipid profile in Emirati population","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2018.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}